For more information visit: www.miltenyibiotec.com/produc...
The MACSima™ Platform takes high-plex spatial protein profiling to a new level. Based on fluorescence microscopy, it enables staining of over 200 markers on a single sample in one run. The MACSima Platform utilizes MICS (MACSima Imaging Cyclic Staining) technology, employing iterative staining cycles with primary, fluorochrome-conjugated antibodies to capture microscopy data of hundreds of markers without compromising the sample. The process comprises three steps, all performed fully automated by the MACSima System. Initially, the sample is stained with multiple fluorochrome-conjugated antibodies. In the subsequent step, an image is captured using the widefield microscope, and to conclude the cycle, the fluorescence signal is erased. This cycle is automatically repeated as many times as necessary, enabling the user to label an unlimited number of markers. The resulting stack of images provides an unprecedented insight into any kind of fixed sample. Your sample is full of information - just waiting to be unlocked.
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,700 employees in 23 countries - all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.
23 ноя 2023
